CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
115956-07-5 | 内-六氢-8-羟基-2,6-亚甲基-2H-喹嗪-3(4H)-酮 | (2a,6a,8a,9ab)-Hexahydro-8-hydroxy-2,6-Methano-2H-quinolizin-3(4H)-one; endo-Hexahydro-hydroxy-2,6-Methano-2H-quinolizin-3-(4H)-one | C10H15NO2 | 详情 | 供应商 | |
115956-12-2 | 多拉司琼 | Dolasteron; (2alpha,6alpha,8alpha,9abeta)-Octahydro-3-oxo-2,6-Methano-2H-quinolizin-8-yl-1H-indole-3-carboxylate | C19H20N2O3 | 详情 | 供应商 | |
115956-13-3 | 甲磺酸多拉司琼 | Dolasetron mesylate; (2alpha,6alpha,8alpha,9abeta)-Octahydro-3-oxo-2,6-Methano-2H-quinolizin-8-yl-1H-indole-3-carboxylate monomethanesulfonate | C20H24N2O6S | 详情 | 供应商 | |
2665-57-8 | Ibogamine-18-carboxylicacid, 13-methoxy-14-[(3a)-17-methoxy-17-oxovobasan-3-yl]-, methyl ester; Conodurine(7CI,8CI); 2,6-Methano-1H-azecino[5,4-b]indole, ibogamine-18-carboxylic acidderiv.; 6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole,ibogamine-18-carboxylic acid deriv.; Vobasan, ibogamine-18-carboxylic acidderiv.; NSC 289066 | C43H52N4O5 | 详情 | 供应商 | ||
2580-82-7 | Ibogamine-18-carboxylicacid, 13-methoxy-12-[(3a)-17-methoxy-17-oxovobasan-3-yl]-, methyl ester; Conoduramine(7CI,8CI); 2,6-Methano-1H-azecino[5,4-b]indole, ibogamine-18-carboxylic acidderiv.; 6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole,ibogamine-18-carboxylic acid deriv.; Vobasan, ibogamine-18-carboxylic acidderiv.; NSC 288651 | C43H52N4O5 | 详情 | 供应商 | ||
803648-75-1 | 1H-2,6-Methano-2-benzazocin-8-ol,3,4,5,6-tetrahydro-6-methyl-; 1H-2,6-Methano-2-benzazocin-8-ol,3,4,5,6-tetrahydro-6-methyl-(9CI) | C13H17NO | 详情 | 供应商 | ||
2299-25-4 | Vobasan-17-oic acid,11-methoxy-1-methyl-3-oxo-, methyl ester (9CI); Ochropine(7CI,8CI); 2,6-Methano-1H-azecino[5,4-b]indole, vobasan-17-oic acid deriv.; Methoxy-Na-methylvobasine | C23H28N2O4 | 详情 | 供应商 | ||
2134-83-0 | Vobasan-17-oic acid,3-oxo-, methyl ester; Vobasine(6CI,7CI,8CI); 2,6-Methano-1H-azecino[5,4-b]indole, vobasan-17-oic acid deriv.; (-)-Vobasine; NSC 267706; Vobasin | C21H24N2O3 | 详情 | 供应商 | ||
2299-26-5 | Vobasan-17-oic acid,19,20-dihydro-3-oxo-, methyl ester, (20a)-; Dregamine(6CI,8CI); 2,6-Methano-1H-azecino[5,4-b]indole, vobasan-17-oic acid deriv.; (-)-Dregamine; 20-Epitabernemontanine; NSC 177392 | C21H26N2O3 | 详情 | 供应商 | ||
56691-99-7 | Vobasan-17-oic acid,19,20-dihydro-3-hydroxy-, methyl ester, (3b,20a)- (9CI); Dregaminol(7CI); 2,6-Methano-1H-azecino[5,4-b]indole, vobasan-17-oic acid deriv.; 19,20b-Dihydrovobasinol; Dregamin-3b-ol | C21H28N2O3 | 详情 | 供应商 | ||
28380-23-6 | Vobasan-10,17-diol,4-demethyl-, (16R)- (9CI); 3,4-Secosarpagine(8CI); 2,6-Methano-1H-azecino[5,4-b]indole, vobasan-10,17-diol deriv.; (16R)-N-Demethylvobasan-10,17-diol; 3,4-Secosarpagan-10,17-diol | C19H24N2O2 | 详情 | 供应商 | ||
56692-00-3 | Vobasan-17-oic acid,19,20-dihydro-3-hydroxy-, methyl ester, (3b,20b)- (9CI); Vobasinol,dihydro- (7CI); 2,6-Methano-1H-azecino[5,4-b]indole, vobasan-17-oic acidderiv.; 19,20a-Dihydrovobasinol; Tabernaemontanin-3b-ol; Tabernaemontaninol; Tabernemontaninol | C21H28N2O3 | 详情 | 供应商 | ||
127951-99-9 | 1H-Indole-3-carboxylicacid, octahydro-3-hydroxy-2,6-Methano-2H-quinolizin-8-yl ester; 2,6-Methano-2H-quinolizine,1H-indole-3-carboxylic acid deriv.; Hydrodolasetron; MDL 74156; Reduceddolasetron | C19H22N2O3 | 详情 | 供应商 | ||
723236-14-4 | 1H-2,6-Methano-2-benzazocin-8-ol,6-ethyl-3,4,5,6-tetrahydro-; 1H-2,6-Methano-2-benzazocin-8-ol,6-ethyl-3,4,5,6-tetrahydro-(9CI) | C14H19NO | 详情 | 供应商 | ||
22200-00-6 | 2,6-Methano-3-benzazocin-8-ol,6,11-diethyl-1,2,3,4,5,6-hexahydro-3-methyl-, [2R-(2a,6a,11R*)]- (9CI); 2,6-Methano-3-benzazocin-8-ol,6,11-diethyl-1,2,3,4,5,6-hexahydro-3-methyl-, cis-(-)- (8CI); (-)-6,11a-Diethyl-1,2,3,4,5,6-hexahydro-3-methyl-2,6-Methano-3-benzazocin-8-ol; FDA 0487; GPA 208 | C17H25NO | 详情 | 供应商 | ||
16808-63-2 | 2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-6,11-dimethyl-; 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-2,6-Methano-3-benzazocin-8-ol; 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-8-hydroxy-2,6-Methano-3-benzazocine; 2'-Hydroxy-5,9-dimethyl-6,7-benzomorphan; 5,9-Dimethyl-2'-hydroxy-6,7-benzomorphan; Norcyclazocine; Normetazocine | C14H19NO | 详情 | 供应商 | ||
133005-41-1 | SKF-10047; [2S-(2ALPHA, 6ALPHA, 11R*)]-1,2,3,4,5,6-HEXAHYDRO-6,11-DIMETHYL-3(2-PROPENYL)-2,6-Methano-3-BENZAZOCIN-8-OL HYDROCHLORIDE; [2S-(2A,6A,11R*)]-1,2,3,4,5,6-HEXAHYDRO-6,11-DIMETHYL-3-(2-PROPENYL)-2,6-Methano-3-BENZAZOCIN-8-OL HYDROCHLORIDE; (+)-NANM HYDROCHLORIDE; (+)-N-ALLYLNORMETAZOCINE HYDROCHLORIDE; (+)-N-ALLYNORMETAZOCINE HYDROCHLORIDE; SKF-10047; (+)-SKF 10047 HYDROCHLORIDE; (+)-NANM hydrochloride, SKF-10047, [2S-(2α, 6α,11R*)]-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(2-propenyl)-2,6-Methano-3-benzazocin-8-ol hydrochloride | C17H24ClNO | 详情 | 供应商 | ||
7488-49-5 | (+)-PENTAZOCINE; (+)-PENTAZOCINE; (11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2α,6α-methano-3-benzazocine-8-ol; (2R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2α,6α-methano-3-benzazocine-8-ol; [2R,6R,11R,(-)]-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-Methano-3-benzazocine-8-ol | C19H27NO | 详情 | 供应商 | ||
359-83-1 | 喷他佐辛 | PENTAZOCINE; PENTAZOCINE; (2alpha,6alpha,11r*)-2-butenyl); (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-Methano-3-benzazocin-8-ol; 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-Methano-3-benza; 2-(3,3-Dimethylallyl)-2',2'-hydroxy-5,9-dimethyl-6,7-benzomorphan; 2-(3,3-dimethylallyl)-2’,2’-hydroxy-5,9-dimethyl-6,7-benzomorphan; 2-(3,3-Dimethylallyl)cyclazocine; 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)- | C19H27NO | 详情 | 供应商 | |
58640-82-7 | (+)-SKF-10047; (+)-SKF-10047; (+)-N-ALLYLNORMETAZOCINE HYDROCHLORIDE ( +)-NANM (SKF 10047); (+)-SK&F10047HCl; (2S-(2a,6a,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(2-propenyl)-2,6-Methano-3-benzazocine-8-ol-hydrochloride; [2S-(2alpha,6alpha,11R*)]-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(2-propenyl)-2,6-Methano-3-benzazocin-8-ol hydrochloride; [2S-(2α,6α,11R*]-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propenyl)-2,6-Methano-3-benzazocin-8-olhydrochloride | C17H24ClNO | 详情 | 供应商 |